From: Effect of the Cardio First Angel™ device on CPR indices: a randomized controlled clinical trial
Treatment administered | Treatment dose, control | |||||
---|---|---|---|---|---|---|
Agent | CFA, n (%) | Control n (%) | p Valueb | CFA, Median (Mean) | Median (Mean) | p Valuec |
Electricity, J | 31 (78) | 28 (70) | 0.61 | 600 (600) | 600 (607) | 0.77 |
Epinephrine, mg | 40 (100) | 40 (100) | NS | 4 (4) | 4 (4) | NS |
Vasopressin, U | 21 (53) | 18 (45) | 0.65 | 40 (40) | 40 (40) | NS |
Atropine, mg | 10 (25) | 11 (28) | 1.00 | 1 (0.9) | 1 (0.7) | 0.14 |
Lidocaine, mg | 13 (33) | 14 (35) | 1.00 | 200 (190) | 120 (124) | <0.0001 |
Amiodarone, mg | 16 (40) | 15 (38) | 1.00 | 450 (384) | 450 (390) | 0.85 |
Sodium bicarbonate, mEq | 8 (20) | 15 (38) | 0.14 | 112 (106) | 89 (94) | 0.48 |
Calcium gluconate, g | 3 (7.5) | 4 (10) | 1.00 | 1 (1) | 1 (1) | NS |
Magnesium sulfate, g | 6 (15) | 3 (8) | 0.48 | 2 (2) | 2 (1) | NS |